Showing results (201-210 of 210) with videos related to
Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 23, 2019
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in TaiwanYi-Heng Li, Jaw-Wen Chen, Tsung-Hsien Lin, et al.Acta Cardiologica Sinica|November 29, 2023
2023 TAMIS/TSOC/TACVPR Consensus Statement for Patients with Acute Myocardial Infarction RehabilitationKuan-Cheng Chen, Chih-Neng Hsu, Cheng-Hsueh Wu, et al.Journal of Hypertension|July 20, 2026
Home blood pressure telemonitoring reveals race-specific patterns of target organ damageDong-Yan Zhang, De-Wei An, Yu-Ling Yu, et al.Frontiers in Cardiovascular Medicine|August 26, 2022
First-in-human pilot trial of combined intracoronary and intravenous mesenchymal stem cell therapy in acute myocardial infarctionLien-Cheng Hsiao, Yen-Nien Lin, Woei-Cherng Shyu, et al.Nature Biotechnology|May 14, 2024
Generation of allogeneic CAR-NKT cells from hematopoietic stem and progenitor cells using a clinically guided culture methodYan-Ruide Li, Yang Zhou, Jiaji Yu, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 25, 2026
2026 Consensus and review of Lipoprotein(a) from Taiwan Society of Lipid and Atherosclerosis: Molecular pathogenesis, epidemiology, clinical implications, and advances in diagnostic strategiesChao-Yun Cheng, Yih-Jer Wu, Chih-Fan Yeh, et al.Med (New York, N.Y.)|August 13, 2025
Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cellsYan-Ruide Li, Zhe Li, Yichen Zhu, et al.Acta Cardiologica Sinica|September 23, 2024
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part ITing-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, et al.Acta Cardiologica Sinica|November 25, 2024
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part IITing-Hsing Chao, Tsung-Hsien Lin, Cheng-I Cheng, et al.Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.Pageof 21